A Randomized Trial of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or <scp>FOLFIRI</scp> /Cetuximab in Chinese Patients With <scp> BRAF <sup>V600E</sup> </scp> Mutant Metastatic Colorectal Cancer: The <scp>NAUTICAL</scp> Study

20260 citationsJournal Articlegold Open Access

Authors

Clinical study registration number: NCT05004350.

Good health and well-being

Published in: Cancer Medicine

Volume 15, Issue 3, pp. e71697-e71697

Field-Weighted Citation Impact: 0.00